XML 51 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - CAD ($)
$ in Thousands
Common Shares
Reserves
Accumulated Other Comprehensive Income
Deficit
Total
Balance at the beginning at Dec. 31, 2020 $ 234,649 $ 15,388 $ 528 $ (158,414) $ 92,151
Balance at the beginning (in shares) at Dec. 31, 2020 22,738,450        
Net income (loss) for the year       (34,916) (34,916)
Other comprehensive income for the year     (3)   (3)
Share based payment expense   731     731
Directors fees paid in deferred stock units   32     32
Shares and units issued for:          
Acquisition of exploration and evaluation assets $ 130       130
Acquisition of exploration and evaluation assets (in shares) 23,611        
Exercise of warrants, options, and deferred share units, performance share units, and restricted share units $ 7,629 (1,264)     6,365
Exercise of warrants, options, and deferred share units, performance share units, and restricted share units (in shares) 1,664,094        
Units issued for cash, net of transaction costs $ 15,933 1,667     17,600
Units issued for cash, net of transaction costs (in shares) 3,871,277        
Debt Conversion Agreement $ 9,063       9,063
Debt Conversion Agreement (in shares) 1,324,985        
ATM Program sales $ 666       666
ATM Program sales (in shares) 112,417        
Convertible Notes Conversion $ 8,145       8,145
Convertible Notes Conversion (in shares) 1,240,019        
Balance at the end at Dec. 31, 2021 $ 276,215 16,554 525 (193,330) $ 99,964
Balance at the end (in shares) at Dec. 31, 2021 30,974,853       30,974,853
Net income (loss) for the year       12,551 $ 12,551
Share based payment expense   1,282     1,282
Directors fees paid in deferred stock units   115     115
Shares and units issued for:          
Exercise of warrants, options, and deferred share units, performance share units, and restricted share units $ 1,439 (492)     947
Exercise of warrants, options, and deferred share units, performance share units, and restricted share units (in shares) 356,156        
ATM Program sales $ 3,701       3,701
ATM Program sales (in shares) 720,865        
Cash, net transaction costs and fair value of derivative $ 2,681 433     3,114
Cash, net transaction costs and fair value of derivative (in shares) 2,345,000        
Convertible Notes Conversion $ 4,835       4,835
Convertible Notes Conversion (in shares) 789,103        
Balance at the end at Dec. 31, 2022 $ 288,871 $ 17,892 $ 525 $ (180,779) $ 126,509
Balance at the end (in shares) at Dec. 31, 2022 35,185,977       35,185,977